Xingxing Su

563 total citations
24 papers, 270 citations indexed

About

Xingxing Su is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Xingxing Su has authored 24 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Oncology. Recurrent topics in Xingxing Su's work include CAR-T cell therapy research (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Xingxing Su is often cited by papers focused on CAR-T cell therapy research (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Xingxing Su collaborates with scholars based in China. Xingxing Su's co-authors include Yong Li, Xilei Xie, Xiaoyun Jiao, Bo Tang, Xu Wang, Fuyan Tang, Yawen Liu, Xu Wang, Yuandeng Luo and Ling Shuai and has published in prestigious journals such as Analytical Chemistry, Science Translational Medicine and Frontiers in Immunology.

In The Last Decade

Xingxing Su

17 papers receiving 267 citations

Peers

Xingxing Su
Huaijiang Xiang China
Yuhan Guo China
Junwei Zhang China
Jingting Zhan China
Lizhou Yue China
Jicheng Duan United States
Yanping Pan China
Shuhong Huang China
Anna Selmi Poland
Yuantao Mao China
Huaijiang Xiang China
Xingxing Su
Citations per year, relative to Xingxing Su Xingxing Su (= 1×) peers Huaijiang Xiang

Countries citing papers authored by Xingxing Su

Since Specialization
Citations

This map shows the geographic impact of Xingxing Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingxing Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingxing Su more than expected).

Fields of papers citing papers by Xingxing Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingxing Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingxing Su. The network helps show where Xingxing Su may publish in the future.

Co-authorship network of co-authors of Xingxing Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xingxing Su. A scholar is included among the top collaborators of Xingxing Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingxing Su. Xingxing Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yingquan, et al.. (2025). Global research hotspots and trends in microglia in ischemic stroke. Frontiers in Immunology. 16. 1622499–1622499.
2.
Wang, Xuepeng, et al.. (2025). The efficacy of acupuncture for post-stroke dysphagia: an overview of systematic reviews and meta-analyses. Frontiers in Neuroscience. 19. 1640471–1640471.
3.
Liu, Yingquan, et al.. (2025). Exploring research trends and hotspots in PI3K/Akt signaling pathway in ischemic stroke: a bibliometric analysis. Frontiers in Molecular Neuroscience. 18. 1613702–1613702. 1 indexed citations
4.
Fang, Lei, Xingxing Su, Jie Zhang, et al.. (2025). Macrophage miR-4524a-5p/TBP promotes β-TrCP -TIM3 complex activation and TGFβ release and aggravates NAFLD-associated fibrosis. Cell Death and Disease. 16(1). 315–315. 3 indexed citations
5.
Kou, Jiahui, et al.. (2025). BCAA metabolism in cancer progression and therapy resistance: The balance between fuel and cell signaling. Frontiers in Pharmacology. 16. 1595176–1595176.
6.
Su, Xingxing, et al.. (2025). Effects of Acupuncture Combined with Conventional Rehabilitation Training for Patients with Post-Stroke Dysphagia: A Randomized Controlled Trial. Journal of Multidisciplinary Healthcare. Volume 18. 3139–3152.
7.
Su, Xingxing, et al.. (2025). Association between triglyceride glucose-waist height ratio and stroke: a population-based study. Frontiers in Endocrinology. 16. 1510493–1510493. 3 indexed citations
8.
Li, Xinting, Xinran Zhao, Xingxing Su, et al.. (2024). IQGAP1 overexpression attenuates chemosensitivity through YAP-mediated ferroptosis inhibition in esophageal squamous cell cancer cells. Archives of Biochemistry and Biophysics. 758. 110064–110064. 6 indexed citations
9.
Wen, Shuqiong, Xingxing Su, Junyi Guo, et al.. (2024). Bcl6 controls the stability and suppressive function of regulatory T cells in head and neck squamous cell carcinoma. Genes & Diseases. 12(4). 101505–101505.
10.
Wang, Qingqing, et al.. (2024). Effect of acupuncture on post-stroke dysphagia: a randomized controlled trial. Frontiers in Neurology. 15. 1391226–1391226. 3 indexed citations
11.
Chen, Zewei, et al.. (2024). Unveiling the atlas of associations between 1,400 plasma metabolites and 24 tumors: Mendelian randomization analyses. Translational Cancer Research. 13(9). 4938–4956.
12.
Ran, Ling, Zhengliang Yue, Qiao Liu, et al.. (2024). The transcription regulator ID3 maintains tumor-specific memory CD8+ T cells in draining lymph nodes during tumorigenesis. Cell Reports. 43(9). 114690–114690. 5 indexed citations
13.
Su, Xingxing, et al.. (2023). Prognostic value and immunological roleof PTPN21 in pan-cancer analysis. Central European Journal of Immunology. 48(2). 111–125. 2 indexed citations
14.
Gao, Weiwu, Ying Tang, Ying Wang, et al.. (2023). Hypoxia-sensitive cells trigger NK cell activation via the KLF4-ASH1L-ICAM-1 axis, contributing to impairment in the rat epididymis. Cell Reports. 42(11). 113442–113442. 3 indexed citations
15.
Liu, Qiao, Lisha Wang, Huayu Lin, et al.. (2022). Tumor-Specific CD4+ T Cells Restrain Established Metastatic Melanoma by Developing Into Cytotoxic CD4– T Cells. Frontiers in Immunology. 13. 875718–875718. 14 indexed citations
16.
Su, Xingxing, Chengcheng Zhang, Hongbo Ma, et al.. (2021). PUM1 is upregulated by DNA methylation to suppress antitumor immunity and results in poor prognosis in pancreatic cancer. Translational Cancer Research. 10(5). 2153–2168. 9 indexed citations
17.
Su, Xingxing, Le Ma, Peng Luo, et al.. (2020). <p>Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway</p>. OncoTargets and Therapy. Volume 13. 12213–12223. 1 indexed citations
18.
Su, Xingxing, Yuandeng Luo, Yan Jiang, et al.. (2019). PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells. Cell Death and Disease. 10(8). 595–595. 36 indexed citations
19.
Xie, Xilei, Xingxing Su, Yong Li, et al.. (2019). A Facile, Versatile, and Highly Efficient Strategy for Peroxynitrite Bioimaging Enabled by Formamide Deformylation. Analytical Chemistry. 91(10). 6872–6879. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huaijiang Xiang Breakdown of academic impact, for papers by Yuhan Guo Breakdown of academic impact, for papers by Junwei Zhang Breakdown of academic impact, for papers by Jingting Zhan Breakdown of academic impact, for papers by Lizhou Yue Breakdown of academic impact, for papers by Jicheng Duan Breakdown of academic impact, for papers by Yanping Pan Breakdown of academic impact, for papers by Shuhong Huang Breakdown of academic impact, for papers by Anna Selmi Breakdown of academic impact, for papers by Yuantao Mao
Rankless by CCL
2026